CID 74051909

Prelissoclinamide 2

Structural Information

Molecular Formula
C33H43N7O6S2
SMILES
CCC(C)C1C2=NC(CS2)C(=O)NC(C3=NC(=CS3)C(=O)NC(C(=O)N4CCCC4C(=O)NC(C(=O)N1)C(C)O)CC5=CC=CC=C5)C
InChI
InChI=1S/C33H43N7O6S2/c1-5-17(2)25-32-37-22(16-48-32)27(42)34-18(3)31-36-23(15-47-31)28(43)35-21(14-20-10-7-6-8-11-20)33(46)40-13-9-12-24(40)29(44)39-26(19(4)41)30(45)38-25/h6-8,10-11,15,17-19,21-22,24-26,41H,5,9,12-14,16H2,1-4H3,(H,34,42)(H,35,43)(H,38,45)(H,39,44)
InChIKey
PBVGQOXVBWQTTN-UHFFFAOYSA-N
Compound name
11-benzyl-23-butan-2-yl-20-(1-hydroxyethyl)-4-methyl-6,25-dithia-3,10,13,19,22,27,28-heptazatetracyclo[22.2.1.15,8.013,17]octacosa-5(28),7,24(27)-triene-2,9,12,18,21-pentone
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

3
Patents

697.2716 Da
Monoisotopic Mass

3.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 698.27888 243.7
[M+Na]+ 720.26082 245.6
[M-H]- 696.26432 238.2
[M+NH4]+ 715.30542 238.8
[M+K]+ 736.23476 242.0
[M+H-H2O]+ 680.26886 247.5
[M+HCOO]- 742.26980 229.3
[M+CH3COO]- 756.28545 242.1
[M+Na-2H]- 718.24627 235.2
[M]+ 697.27105 239.3
[M]- 697.27215 239.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe